Activation of nuclear factor-kappaB during retinal degeneration in rd mice

Hui-Yang Zeng1, Mark O M Tso, Shenghan Lai

  • 1Peking University Eye Center, Peking University Third Hospital, Beijing, China.

Molecular Vision
|June 17, 2008
PubMed
Abstract

Insights

Nuclear factor-kappa beta (NF-kappaB) activation increases during retinal degeneration in rd mice, peaking at postnatal day 12. This suggests NF-kappaB modulation, potentially via microglial activation, plays a role in photoreceptor apoptosis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Ophthalmology

Background:

  • Nuclear factor-kappa beta (NF-kappaB) is crucial for gene regulation in neurodegenerative diseases.
  • Understanding NF-kappaB's role in retinal degeneration is vital for developing therapeutic strategies.

Purpose of the Study:

  • To investigate alterations in NF-kappaB activity during retinal degeneration in rd mice.
  • To explore the specific role of NF-kappaB in photoreceptor apoptosis.

Main Methods:

  • Immunohistochemistry using NF-kappaB P65 antibody to assess nuclear translocation.
  • Western blot and gel shift analysis to quantify NF-kappaB P65 protein and DNA-binding activity.
  • Double labeling with CD11b to identify NF-kappaB expression in microglial cells.

Main Results:

  • NF-kappaB P65 nuclear translocation and DNA-binding activity increased significantly from postnatal day 10, peaking at day 12.
  • Elevated P65 expression persisted from day 12 to day 18.
  • NF-kappaB P65 was found in microglial cells within the outer nuclear layer at day 14.

Conclusions:

  • NF-kappaB is demonstrably activated during the process of retinal degeneration in rd mice.
  • NF-kappaB modulation, possibly through microglial activation, is implicated in the progression of retinal degeneration.

Related Concept Videos